Reports for SANDOZ CANADA INCORPORATED

Company Name
SANDOZ CANADA INCORPORATED

Shortage reports

Actual shortage:

35 (1%)

Anticipated shortage:

9 (0%)

Avoided shortage:

19 (1%)

Resolved:

2320 (97%)

2383

Discontinuation Reports

To be discontinued:

3 (2%)

Discontinued:

131 (96%)

Reversed:

2 (1%)

136

466 (18%)

3 (6%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
METHOTREXATE INJECTION USP 25MG SOLUTION Resolved 2017-03-14 2017-10-18 2612
METHOTREXATE INJECTION USP 25MG SOLUTION Resolved 2018-04-03 2018-07-03 44783
METHOTREXATE INJECTION USP 25MG SOLUTION Resolved 2017-06-06 2017-07-12 12127
METOCLOPRAMIDE HYDROCHLORIDE INJECTION 5MG LIQUID Resolved 2021-01-12 2021-03-02 131397
METOCLOPRAMIDE HYDROCHLORIDE INJECTION 5MG LIQUID Resolved 2023-01-19 2023-02-15 181692
METOCLOPRAMIDE HYDROCHLORIDE INJECTION 5MG LIQUID Resolved 2023-04-04 2023-04-18 188657
METOCLOPRAMIDE HYDROCHLORIDE INJECTION 5MG LIQUID Resolved 2022-10-04 2022-12-12 171074
MICRO CU 0.4MG SOLUTION Resolved 2022-02-04 2022-03-15 154258
MICRO I 100MCG LIQUID Resolved 2022-09-02 2022-10-01 168556
MICRO I 100MCG/ML 10X10MLV LIQUID IN VAIL Resolved 2017-03-14 2017-10-25 2600
MICRO I 100MCG LIQUID Resolved 2020-12-17 2020-12-22 130240
MICRO I 100MCG LIQUID Actual shortage 2025-12-22 2026-02-24 274880
MICRO PLUS 4 REGULAR STRENGTH .1MG 4MCG 1MG .4MG LIQUID Resolved 2019-12-03 2019-12-24 100117
MICRO PLUS 6 (CONCENTRATE) 75MCG 60MCG 10MCG 0.5MG 1MG 5MG LIQUID Resolved 2021-10-25 2021-10-26 147924
MICRO PLUS 6 (PEDIATRIC) 60MCG 20MCG 4MCG 0.1MG 0.4MG 3MG LIQUID Resolved 2022-12-15 2023-08-15 178549
MICRO PLUS 6 (PEDIATRIC) 0.1MG 4MCG 20MCG 3MG 0.4MG 60MCG LIQUID Resolved 2017-03-14 2017-03-21 2592
MICRO ZN 5MG SOLUTION Avoided shortage 2024-08-08 2024-08-13 234797
MICRO ZN 5MG SOLUTION Resolved 2020-12-17 2020-12-22 130245
MICRO ZN 5MG SOLUTION Resolved 2024-08-28 2025-11-26 236151
MICRO ZN 5MG SOLUTION Resolved 2020-04-03 2020-06-22 110746
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ANGIOMAX 250MG POWDER FOR SOLUTION Discontinued 2026-03-16 2026-03-19 280590
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BORTEZOMIB FOR INJECTION SDZ 3.5MG POWDER FOR SOLUTION Discontinued 2026-03-16 2026-03-19 280595
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2024-05-17 2024-05-18 228249
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467
KETOROLAC TROMETHAMINE INJECTION USP 30MG SOLUTION LIQUID Discontinued 2025-08-04 2025-08-05 264341
LORAZEPAM INJECTION USP 2MG SOLUTION Discontinued 2020-02-14 2020-03-12 106265

Showing 1 to 20 of 136